266 related articles for article (PubMed ID: 26577841)
1. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
Bombard Y
Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
[No Abstract] [Full Text] [Related]
2. Translating genomics in cancer care.
Bombard Y; Bach PB; Offit K
J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
[TBL] [Abstract][Full Text] [Related]
3. H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine.
Borro M; Simmaco M; Aceti A; Barni S; De Luca A; Fineschi V; Frati P; Girardi P; Miozzo M; Nati G; Nicoletti F; Santini D; Marchetti P
Curr Pharm Biotechnol; 2016; 17(10):926-9. PubMed ID: 27194357
[TBL] [Abstract][Full Text] [Related]
4. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
[TBL] [Abstract][Full Text] [Related]
5. Toward clinical genomics in everyday medicine: perspectives and recommendations.
Delaney SK; Hultner ML; Jacob HJ; Ledbetter DH; McCarthy JJ; Ball M; Beckman KB; Belmont JW; Bloss CS; Christman MF; Cosgrove A; Damiani SA; Danis T; Delledonne M; Dougherty MJ; Dudley JT; Faucett WA; Friedman JR; Haase DH; Hays TS; Heilsberg S; Huber J; Kaminsky L; Ledbetter N; Lee WH; Levin E; Libiger O; Linderman M; Love RL; Magnus DC; Martland A; McClure SL; Megill SE; Messier H; Nussbaum RL; Palaniappan L; Patay BA; Popovich BW; Quackenbush J; Savant MJ; Su MM; Terry SF; Tucker S; Wong WT; Green RC
Expert Rev Mol Diagn; 2016; 16(5):521-32. PubMed ID: 26810587
[TBL] [Abstract][Full Text] [Related]
6. Establish good genomic practice to guide medicine forward.
Barker RW; Brindley DA; Schuh A
Nat Med; 2013 May; 19(5):530. PubMed ID: 23652098
[No Abstract] [Full Text] [Related]
7. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
8. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
Wilson BJ; Miller FA; Rousseau F
J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
[TBL] [Abstract][Full Text] [Related]
9. Personalized genome structure via single gamete sequencing.
Lyu R; Tsui V; McCarthy DJ; Crismani W
Genome Biol; 2021 Apr; 22(1):112. PubMed ID: 33874978
[TBL] [Abstract][Full Text] [Related]
10. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
Conti R; Veenstra DL; Armstrong K; Lesko LJ; Grosse SD
Med Decis Making; 2010; 30(3):328-40. PubMed ID: 20086232
[TBL] [Abstract][Full Text] [Related]
11. [Ethical and social issues associated with genomic medicine].
Barazzetti G; Kaufmann A; Benaroyo L
Praxis (Bern 1994); 2014 May; 103(10):573-7. PubMed ID: 24800769
[TBL] [Abstract][Full Text] [Related]
12. Precision Medicine: From Science To Value.
Ginsburg GS; Phillips KA
Health Aff (Millwood); 2018 May; 37(5):694-701. PubMed ID: 29733705
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
14. Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges.
Tekola-Ayele F; Rotimi CN
Public Health Genomics; 2015; 18(4):242-7. PubMed ID: 26138992
[TBL] [Abstract][Full Text] [Related]
15. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics.
Johnson JA; Elsey AR; Clare-Salzler MJ; Nessl D; Conlon M; Nelson DR
Pharmacogenomics; 2013 May; 14(7):723-6. PubMed ID: 23651020
[TBL] [Abstract][Full Text] [Related]
16. What Precision Medicine Can Learn from Rare Genetic Disease Research and Translation.
Tabor HK; Goldenberg A
AMA J Ethics; 2018 Sep; 20(9):E834-840. PubMed ID: 30242814
[TBL] [Abstract][Full Text] [Related]
17. Moral Duties of Genomics Researchers: Why Personalized Medicine Requires a Collective Approach.
Vos S; van Delden JJM; van Diest PJ; Bredenoord AL
Trends Genet; 2017 Feb; 33(2):118-128. PubMed ID: 28017398
[TBL] [Abstract][Full Text] [Related]
18. Essential elements of personalized medicine.
Burke W; Brown Trinidad S; Press NA
Urol Oncol; 2014 Feb; 32(2):193-7. PubMed ID: 24321254
[TBL] [Abstract][Full Text] [Related]
19. Tensions in ethics and policy created by National Precision Medicine Programs.
Minari J; Brothers KB; Morrison M
Hum Genomics; 2018 Apr; 12(1):22. PubMed ID: 29665847
[TBL] [Abstract][Full Text] [Related]
20. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
